eISSN: 2449-9315
ISSN: 1234-8279
Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
1/2020
vol. 36
 
Share:
Share:
Review paper

Sleep disorders in patients with multiple sclerosis

Karolina Katarelos
1
,
Agnieszka Piechal
1, 2
,
Iwona Kurkowska-Jastrzębska
1

  1. 2nd Department of Neurology, Institute of Psychiatry and Neurology
  2. Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology
Farmakoterapia w Psychiatrii i Neurologii 2020, 36 (1), 41–5
Online publish date: 2021/12/03
Article file
Get citation
 
 
1. Allen RP, Auerbach S, Bahrain H, Auerbach M, Earley CJ. The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia. Am J Hematol 2013; 88(4): 261–4.
2. American Academy of Sleep Medicine. International Clas sification of Sleep Disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine 2014.
3. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders DSM-V, American Psychiatric Publishing 2013.
4. Amtmann D, Askew RL, Kim J, Chung H, Ehde DM, Bom bardier CH, et al. Pain affects depression through anxiety, fatigue, and sleep in multiple sclerosis. Rehabil Psychol 2015; 60(1): 81–90.
5. Benedict RH, Wahlig E, Bakshi R. Predicting quality of life in multiple sclerosis: accounting for physical disability, fa tigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005; 231: 29–34.
6. Bishop M, Rumrill PD. Multiple sclerosis: Etiology, symp toms, incidence and prevalence, and implications for com munity living and employment. Work 2015; 52(4): 725–734.
7. Bøe LHM, Aae TF, Indrevåg W. Poor sleep in patients with multiple sclerosis. PLoS One 2012; 7(11): e49996.
8. Braley TJ, Boudreau EA. Sleep Disorders in Multiple Sclero sis. Curr Neurol Neurosci Rep 2016; 16(5): 50.
9. Braley TJ, Chervin RD. Fatigue in multiple sclerosis: me chanisms, evaluation, and treatment. Sleep 2010; 33(8): 1061–1067.
10. Braley TJ, Chervin RD. A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosis. Ther Adv Neurol Disord 2015; 8(6): 294–31.
11. Braley TJ, Segal BM, Chervin RD. Sleep-disordered breathing in multiple sclerosis. Neurology 2012; 79(9): 929–36.
12. Braley TJ, Segal BM, Chervin RD. Obstructive sleep apnea and fatigue in patients with multiple sclerosis. J Clin Sleep Med 2014; 10(2): 155–62.
13. Braley TJ, Kratz AL, Kaplish N, Chervin RD. Sleep and Co gnitive Function in Multiple Sclerosis. Sleep 2016; 39(8): 1525–33.
14. Brass SD, Li CS, Auerbach S. The underdiagnosis of sleep disorders in patients with multiple sclerosis. J Clin Sleep Med 2014; 10(9): 1025–1031.
15. Bruno E, Nicoletti A, Messina S, Lo Fermo S, Raciti L, Quat trocchi G, et al. Restless legs syndrome and multiple sclero sis: a population based case-control study in Catania, Sicily. Eur J Neurol 2015; 22(6): 1018–21.
16. Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, et al. Neuropathic pain. Nat Rev Dis Primers 2017; 3: 17002.
17. Connor JR, Ponnuru P, Lee B-Y, Podskalny GD, Alam S, Allen RP, et al. Postmortem and imaging based analyses reveal CNS decreased myelination in restless legs syndrome. Sleep Med 2011; 12: 614e9.
18. Corcos J, Przydacz M, Campeau L, Gray G, Hickling D, Honeine C, et al. CUA guideline on adult overactive bladder. Can Urol Assoc J 2017; 11(5): E142–E173.
19. Cote I, Trojan D, Kaminska M, Cardoso M, Benedetti A, Weiss D. Impact of sleep disorder treatment on fatigue in multiple sclerosis. Mult Scler 2013; 19: 480–489.
20. Čarnická Z, Kollár B, Šiarnik P, Krížová L, Klobučníková K, Turčáni P. Sleep disorders in patients with multiple sclero sis. J Clin Sleep Med 2015; 11(5): 553–557.
21. Damasceno A, Moraes AS, Farias A, Damasceno BP, dos San tos L, Cendes F. Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: a preli minary study. J Neurol Sci 2015; 353: 166–168.
22. Farhadi N, Oryan S, Nabiuni M. Serum levels of melatonin and cytokines in multiple sclerosis. Biom J 2014; 37: 90–92.
23. Finan PH, Goodin BR, Smith MT. The Association of Sleep and Pain: An Update and a Path Forward. J Pain 2013; 14(12): 1539–1552.
24. Foschi M, Rizzo G, Liguori R, Avoni P, Mancinelli L, Lugaresi A, et al. Sleep-related disorders and their relationship with MRI findings in multiple sclerosis. Sleep Med 2019; 56: 90–97.
25. Gałecki P, Szulc A. Psychiatria. Edra Urban & Partner, Wro cław 2018; wyd. 1.
26. Gholipour T, Ghazizadeh T, Babapour S. Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis. Iran J Allergy Asthma Immunol 2015; 14: 91–97.
27. Heesen C, Nawrath L, Reich C, Bauer N, Schulz KH, Gold SM. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry 2006; 77(1): 34–9.
28. Janardhan V, Bakshi R. Quality of life in patients with mul tiple sclerosis: the impact of fatigue and depression. J Neurol Sci 2002; 205: 51–58.
29. Kalb R, Beier M, Benedict RH, Charvet L, Costello K, Fein stein A, et al. Recommendations for cognitive screening and management in multiple sclerosis care. Mult Scler 2018; 24(13): 1665–1680.
30. Kaminska M, Kimoff R, Benedetti A, Robinson A, Bar-Or A, Lapierre Y, et al. Obstructive sleep apnea is associated with fatigue in multiple sclerosis. Mult Scler J 2011; 18(8): 1159–1169.
31. Kaminska M, Trojan DA, Kimoff RJ. Association between OSA and severe fatigue in patients with multiple sclerosis (MS). J Clin Sleep Med 2014; 10(6): 707.
32. Kaynak H, Altintaş A, Kaynak D, Uyanik O, Saip S, Ağaoğlu J, et al. Fatigue and sleep disturbance in multiple sclerosis. Eur J Neurol 2006; 13(12): 1333–9.
33. Kuzminska M. Obturacyjny bezdech senny – czy jest proble mem ludzi starszych? Post Nauk Med 2011; 54(5): 440–445.
34. Lee J, Nicholl DDM, Ahmed SB, Loewen AHS, Hemmelgarn BR, Beecroft JM, et al. The prevalence of restless legs syn drome across the full spectrum of kidney disease. J Clin Sleep Med 2013; 9:455e9.
35. Maestri M, Romigi A, Schirru A, Fabbrini M, Gori S, Bo nuccell, et al. Excessive daytime sleepiness and fatigue in neurological disorders. Sleep Breath 2019 Aug 23.
36. Manconi M, Fabbrini M, Bonanni E, Filippi M, Rocca M, Murri L, et al. High prevalence of restless legs syndrome in multiple sclerosis. Eur J Neurol 2007; 14:534e9.
37. Manconi M, Govoni V, De Vito A, Economou NT, Cesnik E, Casetta I, et al. Restless legs syndrome and pregnancy. Neu rology 2004; 63(6): 1065–9.
38. Morse AM, Kothare SV. Sleep disorders and concussion. Handb Clinic Neurol 2018; 158 127–134.
39. Najafi MR, Toghianifar N, Etemadifar M, Haghighi S, Maghzi AH, Akbari M. Circadian rhythm sleep disorders in patients with multiple sclerosis and its association with fatigue: A ca se-control study. J Res Med Sci 2013; 18(Suppl 1): S71-3.
40. O’Connor AB, Schwid SR, Herrmann DN, Markman JD, Dwo rkin RH. Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 2008; 137(1): 96–111.
41. Plywaczewski R, Brzecka A, Bielicki P, Czajkowska-Malinow ska M, Cofta S, Jonczak L. Zalecenia Polskiego Towarzystwa Chorób Płuc dotyczące rozpoznawania i leczenia zaburzeń oddychania w czasie snu (ZOCS) u dorosłych. Pneumonol Alergol Pol 2013; 81(3): 221–258.
42. Sadeghi Bahmani D, Kesselring J, Papadimitriou M, Bansi J, Pühse U, Gerber M, et al. In Patients With Multiple Sclerosis, Both Objective and Subjective Sleep, Depression, Fatigue, and Paresthesia Improved After 3 Weeks of Regular Exercise. Front Psychiatry 2019; 10: 265.
43. Sakkas GK, Giannaki CD, Karatzaferi C, Manconi M. Sle ep Abnormalities in Multiple Sclerosis. Curr Treat Options Neurol 2019; 21(1): 4.
44. Sateia MJ. International classification of sleep disorders­-third edition: highlights and modifications. Chest 2014; 146(5): 1387–1394.
45. Sater RA, Gudesblatt M, Kresa-Reahl K, Brandes DW, Sa ter PA. The relationship between objective parameters of sleep and measures of fatigue, depression, and cognition in multiple sclerosis. Mult Scler J Exp Transl Clin 2015; 1: 2055217315577828.
46. Sieminski M, Losy J, Partinen M. Restless legs syndrome in multiple sclerosis. Sleep Med Rev 2015; 22: 15-22.
47. Simpson L, Hillman DR, Cooper MN, Ward KL, Hunter M, Cullen S, et al. High prevalence of undiagnosed obstructi ve sleep apnoea in the general population and methods for screening for representative controls. Sleep Breath 2013; 17(3): 967–73.
48. Skarlis C, Anagnostouli M. The role of melatonin in Multiple Sclerosis. Neurol Sci 2019 Dec 16
49. Stanton BR, Barnes F, Silber E. Sleep and fatigue in multiple sclerosis. Mult Scler 2006; 12(4): 481–6.
50. Steiger A, Pawlowski M. Depression and Sleep. Int J Mol Sci 2019; 20(3), pii:E607.
51. Stenager E, Knudsen L, Jensen K. Acute and chronic pain syndromes in multiple sclerosis. A 5-year follow-up study. Ital J Neurol Sci 1995; 16(9): 629–32.
52. Szczeklik A, Gajewski A. Interna Szczeklika. MP, Kraków 2019, wyd. 10.
53. Tachibana N, Howard RS, Hirsch NP, Miller DH, Moseley IF, Fish D. Sleep problems in multiple sclerosis. Eur Neurol 1994; 34(6): 320–3.
54. Taphoorn MJ, van Someren E, Snoek FJ, Strijers RL, Swaab DF, Visscher F, et al. Fatigue, sleep disturbances and circa dian rhythm in multiple sclerosis. J Neurol 1993; 240(7): 446–8.
55. Thorpy MJ. Classification of sleep disorders. Neurothera peutics. 2012; 9(4): 687–701.
56. Tonetti L, Camilli F, Giovagnoli S, Natale V, Lugaresi A. Circa dian Activity Rhythm in Early Relapsing-Remitting Multiple Sclerosis. J Clin Med 2019; 8(12), pii:E2216.
57. Veauthier C. Sleep Disorders in Multiple Sclerosis. Review. Curr Neurol Neurosci Rep 2015; 15(5): 21.
58. Veauthier C, Radbruch H, Gaede G, Pfueller CF, Dörr J, Bell mann-Strobl J, et al. Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectio nal study. Mult Scler 2011; 17(5): 613–22.
59. Vega R, Miró J, Esteve R, Ramírez-Maestre C, López-Mar tínez AE, Jensen MP. Sleep disturbance in individuals with physical disabilities and chronic pain: The role of physical, emotional and cognitive factors. Disabil Health J 2019; 12(4): 588–593.
60. Vitkova M, Gdovinova Z, Rosenberger J, Szilasiova J, Nagyová I, Mikula P, et al. Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration. Disabil Health J 2014; 7(4): 466–71.
61. Wichniak A, Jankowski KS, Skalski M, Skwarło-Sońta K, Zawilska JB, Żarowski M, et al. Standardy leczenia zaburzeń rytmu okołodobowego snu i czuwania opracowane przez Pol skie Towarzystwo Badań nad Snem i Sekcję Psychiatrii Bio logicznej Polskiego Towarzystwa Psychiatrycznego. Część I. Fizjologia, metody oceny i oddziaływania terapeutyczne. Psychiatr Pol 2017; 61: 1–22.
62. Wojtas A, Ciszewski S. Epidemiologia bezsenności. Psychia tria 2011; 8(3): 79–83.
63. World Health Organization. Classification of diseases (ICD) 2018. http://www.who.int/classifications/icd/en/
64. Wright LJ. Identifying and treating pain caused by MS. J Clin Psychiatry 2012; 73(7): e23.
65. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep- disordered breathing among middle-a ged adults. N Engl J Med 1993; 328(17): 1230–1235.

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.